244621-27-0

Basic information

• Product Name: 2-(3-bromophenyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one
• Synonyms: 2-(3-bromophenyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one
• CAS NO: 244621-27-0
• Molecular Weight: 304.143
• Mol File: 244621-27-0.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-(3-bromophenyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3-bromophenyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one(244621-27-0)
• EPA Substance Registry System: 2-(3-bromophenyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one(244621-27-0)

Safety Data

• Hazardous Substances Data: 244621-27-0(Hazardous Substances Data)

Upstream product

• 51-19-4 2-aminophenol hydrochloride 
• 163339-67-1 methyl 2-bromo-2-(3-bromophenyl)acetate 

Downstream Products

• 244621-26-9 2-(3-cyanophenyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one 
• 244621-34-9 3-(4-[5-[(2R,6S)-2,6-dimethyltetrahydro-1(2H)-pyridinyl]pentyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl)-1-N-hydroxytrifluoroacetobenzenecarboximidamide 
• 244618-40-4 3-(4-[5-[(2R,6S)-2,6-dimethyltetrahydro-1(2H)-pyridinyl]pentyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl)-1-N-hydroxybenzenecarboximidamide 

Relevant articles and documents

Benzoxazinoes/benzothiazinones as serine protease inhibitors

This invention discloses benzoxazinone and benzothiazinone compounds which display inhibitory effects on serine proteases such as factor Xa, thrombin, and/or factor VIIa. The invention also discloses pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable compositions comprising the compounds or their salts, and methods of using them as therapeutic agents for treating or preventing disease states in mammals characterized by abnornal thrombosis.